Public consultation survey for the Rapid Review of PBS medicines for relapsing-remitting multiple sclerosis (RRMS) (December 2026 PBAC meeting)

Overview

Consultation is now open for the rapid review of Pharmaceutical Benefits Scheme (PBS) medicines for relapsing-remitting multiple sclerosis (RRMS). For further information on the review including background, processes, timelines and guiding research questions, please refer to the RRMS review website.

The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public.

Input can be submitted via the online survey.  A copy of the questions asked in the survey and additional guidance can be downloaded below under ‘Related’ to assist your preparation.

There is the option to upload a file with your submission. The preferred file types are PDF or Microsoft Word, however other file types will be accepted, provided they are no larger than 25mb. If your file is too large, or you wish to upload more than one file, please contact commentsPBAC@health.gov.au

You can save and come back at any time to your response before the consultation closing date.

Once you have submitted, a copy of your submission will be emailed to the contact email address provided.

Feedback can also be sent by emailing the survey in Word format, along with any relevant files, to  commentsPBAC@health.gov.au

Please note that in the last question we welcome your comments and suggestions on ways to improve the survey and this process. All responses are considered after each round of consultation, and improvements are then made to the survey and its guidance where appropriate.

How to provide input

• Input can be submitted via the online survey.  A copy of the questions asked in the survey and additional guidance can be downloaded below under ‘Related’ to assist your preparation.
• There is the option to upload a file with your submission. The preferred file types are PDF or Microsoft Word, however other file types will be accepted, provided they are no larger than 25mb. If your file is too large, or you wish to upload more than one file, please contact commentsPBAC@health.gov.au
• You can save and come back at any time to your response before the consultation close date.
• Once you have submitted, a copy of your submission will be emailed to the contact email address provided.
• It is important that all of the questions in the survey are answered. Please be aware that if you only complete the 'Contact details' section of the survey, your input will be considered incomplete. Consequently, your contribution will not be reflected in the consultation summary for the PBAC's consideration.

Providing input on more than one medicine? You will need to complete a separate survey for each medicine. Alternatively, email your input to commentsPBAC@health.gov.au

In the last question we welcome your comments and suggestions on ways to improve the survey and this process. All responses are considered after each round of consultation, and improvements are then made to the survey and its guidance where appropriate.